Sign in to view content

Analysis of Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) in Patients With nAMD

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2021

Related

New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases
Alay S. Banker, MD
Annual Meeting Talks
2018
Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian nAMD and DME Patients in a Real-World Setting: The PRECISE Study
Ananda Kalevar, MD, FRCS(C), DABO
On Demand Cases, Courses, and Papers
2020
LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results
Carl C. Awh, MD, FASRS
Annual Meeting Talks
2018

Category: AMD-Neovascular

See more